Finance

Lists
Why is VERA down 4,03%?
Dive Deeper
VERA:NASDAQ
Vera Therapeutics, Inc
30,99 US$
-4,03%
(-1,30) 1D
30,76 US$
-0,73% (-0,23)
After hours
Closed: 1 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VERA...
Open
32,14 US$
High
32,44 US$
Low
30,87 US$
Mkt. cap
2,23 მლრდ.
Avg. vol.
2,34 მლნ.
Volume
350,00
52-wk high
56,04 US$
52-wk low
23,05 US$
EPS
-5,86 US$
Beta
0,96
Shares outstanding
72,06 მლნ.
No. of employees
361
Open
32,14 US$
High
32,44 US$
Low
30,87 US$
Mkt. cap
2,23 მლრდ.
Avg. vol.
2,34 მლნ.
Volume
350,00
52-wk high
56,04 US$
52-wk low
23,05 US$
EPS
-5,86 US$
Beta
0,96
Shares outstanding
72,06 მლნ.
No. of employees
361
News stories
From web sources and news partners
About Vera Therapeutics, Inc
CEO-
Employees361
Founded2016
HeadquartersBrisbane, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteveratx.com
Analyst ratings
Based on 12 analysts giving stock ratings to VERA in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for VERA in the last 3 months.
Highest
Current 30,99 US$
100,00 US$ (+222,68%)
Average
75,40 US$ (+143,30%)
Lowest
34,00 US$ (+9,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
90,00 US$
+190,4%
10/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
59,00 US$
+90,4%
09/16/2026
Laura Chico
Wedbush
Hold
Maintained
34,00 US$
+9,7%
09/16/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
Dina Ramadane
Bank of America Securities
Buy
Reiterated
66,00 US$
+113%
09/15/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
70,00 US$
+125,9%
09/15/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
90,00 US$
+190,4%
09/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
09/15/2026
Ritu Baral
TD Cowen
Buy
Maintained
78,00 US$
+151,7%
08/31/2026
Vamil Divan
Guggenheim
Buy
Reiterated
76,00 US$
+145,2%
08/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Maintained
100,00 US$
+222,7%
08/10/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
91,00 US$
+193,6%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
70,00 US$
+125,9%
06/11/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 US$
+190,4%
06/05/2026
Andy Chen
Wolfe Research
Buy
Maintained
88,00 US$
+184%
06/02/2026
Unknown Analyst
Wedbush
Hold
Maintained
35,00 US$
+12,9%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
56,47 მლნ.
59,31 მლნ.
86,01 მლნ.
60,08 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,46 მლნ.
34,90 მლნ.
39,12 მლნ.
52,41 მლნ.
Operating expense
83,93 მლნ.
94,21 მლნ.
125,13 მლნ.
112,49 მლნ.
Total operating expenses
83,93 მლნ.
94,21 მლნ.
125,13 მლნ.
112,49 მლნ.
Operating income
-83,93 მლნ.
-94,21 მლნ.
-125,13 მლნ.
-112,49 მლნ.
Other non operating income
-137,00 ათ.
-303,00 ათ.
-32,00 ათ.
-483,00 ათ.
EBT including unusual items
-80,29 მლნ.
-91,10 მლნ.
-121,03 მლნ.
-109,47 მლნ.
EBT excluding unusual items
-80,29 მლნ.
-90,90 მლნ.
-120,63 მლნ.
-109,47 მლნ.
Income tax expense
-
1,00 ათ.
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-80,29 მლნ.
-91,10 მლნ.
-121,03 მლნ.
-109,47 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-1,26
-1,39
-1,69
-1,52
Interest and investment income
5,74 მლნ.
5,52 მლნ.
6,36 მლნ.
5,35 მლნ.
Interest expense
-1,96 მლნ.
-1,90 მლნ.
-1,82 მლნ.
-1,85 მლნ.
Net interest expenses
3,78 მლნ.
3,61 მლნ.
4,53 მლნ.
3,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-83,80 მლნ.
-94,07 მლნ.
-124,99 მლნ.
-112,36 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები